Advertisement
Yeray in action against Neymar last season. PA Archive/PA Images

Athletic Bilbao defender leaves Spain U21 squad for chemotherapy treatment

Yeray, who was treated for cancer last year, needs surgery after an anomaly was detected during medical checks.

ATHLETIC BILBAO DEFENDER Yeray requires chemotherapy after an anomaly was found during a medical examination on Monday.

The 22-year-old has left the Spain U21 squad to undergo treatment and is expected to be sidelined for three months, the club confirmed.

“During a radiological check-up done on June 12, the latest of the follow-up tests done to monitor the progress of the testicular tumour that was detected and removed in December 2016, an anomaly (adenopathy) has been detected that needs to be treated and hence, in the coming days the player will undergo complementary treatment (chemotherapy) indicated by the specialists,” an Athletic statement released on Tuesday read.

“The player will leave the U-21 Spain national team on June 13 and the estimated time of absence is approximately three months. Just as we expressed when we first found out about his illness, Athletic Bilbao is at the disposal of Yeray and requests respect and discretion for the player and his family.”

Yeray, who made his senior debut last September, was diagnosed with testicular cancer in December and immediately had surgery to remove the tumour.

The centre-back returned to first-team action in February and later that month signed a contract extension through to 2022.

He made a total of 35 appearances in all competitions in 2016-17 and earned a place in Spain’s U-21 squad for the European Championship finals in Poland this month.

The42 is on Instagram! Tap the button below on your phone to follow us!

Griezmann ends speculation by signing new Atleti deal with €100m buy-out clause

‘It would be a sea of green’ – McClean on prospect of Ireland and Northern Ireland qualifying for World Cup

Author
View 8 comments
Close
8 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.